Elizabeth Akbulut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elizabeth Akbulut has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Abraham Aviv
Rutgers-New Jersey Medical School, Center of Human Development and Aging
1 shared publication George S. Yap
Department of Medicine, Rutgers-New Jersey Medical School, Center for Immunity and Inflammation
1 shared publication- Luis Garza-Martinez
Department of Pathology, Immunology, and Laboratory Medicine, Rutgers-New Jersey Medical School
1 shared publication Nica M. Aquino
Department of Pathology, Immunology, and Laboratory Medicine, Rutgers-New Jersey Medical School
1 shared publicationPaolo S. Turano
Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers-New Jersey Medical School, Center for Cell Signaling
1 shared publication- Patricia Fitzgerald-Bocarsly
Department of Pathology, Immunology, and Laboratory Medicine, Rutgers-New Jersey Medical School
1 shared publication
Latest Publications
- Open Access
- 3 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (45)
Senescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy
Senescent cells play important roles in various biological processes that promote fitness and health; however, their timely elimination by immune cells is critical to maintain tissue homeostasis and prevent disease. Despite this, senescent cells accumulate systemically with age, suggesting that certain immune cells also become senescent and dysfunctional during aging. In support of this, we previously demonstrated that CD8 T cells, immune cells capable of targeting senescent cells, increasingly develop characteristics of senescence with advancing age in humans. Here, we characterized the senescence state of human SA-βGal-expressing (SA-βGal high ) CD8 T effector memory (EM) cells, their functional capabilities, and their enrichment in aging and disease. Single-cell RNA sequencing revealed that SA-βGal high CD8 T cells with unique transcriptional signatures develop in all stages of T cell differentiation, including in CD8 T EM cells, which increased in abundance with human aging. SA-βGal high CD8 T EM cells expressed various classical markers of senescence and were significantly impaired in their ability to proliferate, produce cytokines, and eliminate senescent human stromal cells. Gene signatures of senescent SA-βGal high CD8 T EM cells were enriched in CD8 T cells from older human donors, patients with age-related disorders, cancer, and in smokers. Furthermore, we show that T cell senescence is distinct from and dominant over T cell exhaustion, limiting the response of CD8 T EM cells to immune checkpoint blockade. Collectively, our study demonstrates that senescence impairs CD8 T EM cell function and reveals the involvement of senescent and dysfunctional CD8 T EM cells in aging, disease, smoking, and responses to immunotherapy.
- 3 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (45)
Open AccessSenescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy
Senescent cells play important roles in various biological processes that promote fitness and health; however, their timely elimination by immune cells is critical to maintain tissue homeostasis and prevent disease. Despite this, senescent cells accumulate systemically with age, suggesting that certain immune cells also become senescent and dysfunctional during aging. In support of this, we previously demonstrated that CD8 T cells, immune cells capable of targeting senescent cells, increasingly develop characteristics of senescence with advancing age in humans. Here, we characterized the senescence state of human SA-βGal-expressing (SA-βGal high ) CD8 T effector memory (EM) cells, their functional capabilities, and their enrichment in aging and disease. Single-cell RNA sequencing revealed that SA-βGal high CD8 T cells with unique transcriptional signatures develop in all stages of T cell differentiation, including in CD8 T EM cells, which increased in abundance with human aging. SA-βGal high CD8 T EM cells expressed various classical markers of senescence and were significantly impaired in their ability to proliferate, produce cytokines, and eliminate senescent human stromal cells. Gene signatures of senescent SA-βGal high CD8 T EM cells were enriched in CD8 T cells from older human donors, patients with age-related disorders, cancer, and in smokers. Furthermore, we show that T cell senescence is distinct from and dominant over T cell exhaustion, limiting the response of CD8 T EM cells to immune checkpoint blockade. Collectively, our study demonstrates that senescence impairs CD8 T EM cell function and reveals the involvement of senescent and dysfunctional CD8 T EM cells in aging, disease, smoking, and responses to immunotherapy.